Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $92 from $94 and keeps an Outperform rating on the shares. The firm updated estimates in the life insurance group post the Q2 reports.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET: